Ramucirumab and paclitaxel in second or greater lines of therapy in patients with HER2-positive gastroesophageal cancer: a single center study
雷莫芦单抗联合紫杉醇用于HER2阳性胃食管癌患者的二线或以上治疗:一项单中心研究
期刊:Oncologist
影响因子:4.2
doi:10.1093/oncolo/oyaf037
Bach, Yvonne; Sharma, Divya; Aoyama, Hiroko; Ma, Lucy X; Barron, Carly C; Wang, Xin; Akhtar, Sokaina; Yang, Yahan; St Bernard, Alana; McLaughlin, Ronan; Megid, Thais B C; Farooq, Abdul R; Chen, Eric X; Jang, Raymond W J; Elimova, Elena